About Careers MedBlog Contact us

US Pharma Giant Pfizer Takes Over $17 Billion Hospira

by Dr. Trupti Shirole on February 6, 2015 at 11:49 AM
Font : A-A+

US Pharma Giant Pfizer Takes Over $17 Billion Hospira

US pharmaceutical giant Pfizer will expand its line of drugs and therapies with the takeover of $17 billion Hospira. The deal has been approved by the boards of both companies, and will importantly add Hospira's portfolio of sterile injectable treatments and biosimilar drugs to Pfizer's broad pharmaceutical offerings.

Pfizer will pay $90 a share in cash for Hospira, which is nearly 40 percent premium.


The companies said, "The market for sterile injectables, injectable drugs which can treat a range of maladies from pain to cancer, will be about $70 billion in 2020. The world market for biosimilars, officially approved adaptations of off-patent drugs made by others, will hit $20 billion in 5-years."

Pfizer said, "Hospira's product line strategically complements its own and will add a growing international revenue stream."

Pfizer chairman and chief executive Ian Read said, "Hospira's business aligns well with our new commercial structure and is an excellent strategic fit for our Global Established Pharmaceutical business, which will benefit from a significantly enhanced product portfolio in growing markets."

Source: Medindia


Recommended Reading

Latest Drug News

 Understanding Why Aspirin is a Magic Drug for Inflammation
New discoveries about aspirin's interplay between messenger molecules that are crucial in the inflammatory proves again that it is a powerful anti-inflammatory drug.
Is Fomepizole the Key to Overcoming Antibiotic-Resistant Pneumonia?
The new drug target sheds insights into strategies to fight drug-resistant S. pneumoniae, stated research.
 Combination Therapy Benefits Septic Shock Patients
The effectiveness of adding fludrocortisone to hydrocortisone vs hydrocortisone alone among patients with septic shock was analyzed using target trial emulation.
Are Painkillers Safe for Back Pain?
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

US Pharma Giant Pfizer Takes Over $17 Billion Hospira Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests